Clinuvel Pharmaceuticals (CLVLY)

[FarmaZutical]

New investors:

Welcome to the CLVLY board. You’ve probably heard about the company or the product and found your way to this board to get more information.

The best way to start is by reading this independent analyst report by Sphene Capital:

http://www.more-ir.de/d/16065.pdf

CLVLY and CLVLF are ADRs of the Australian listed stock, CUV. The stock is also traded on the German stock exchange; in Frankfurt under UR9.

The company already has a Nasdaq International Designation but plans to list “on a foreign exchange” before July, 2019 according to the latest PR. The best would be a Nasdaq listing and a relocation of the company’s headquarter to the US. Currently, it’s located in Melbourne, Australia with its main operations in Switzerland and London, GB.

The stock is extremely tightly held by institutional investors and long time believers who have been here for more than 10 years.

Happy reading and don’t hesitate to ask questions.